Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-19-001526
Filing Date
2019-05-10
Accepted
2019-05-10 09:22:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G 6702
  Complete submission text file 0000315066-19-001526.txt   8412
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90199 | Film No.: 19813081
SIC: 2836 Biological Products, (No Diagnostic Substances)